Atlas Trials

An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL®

Clinical trial NCT06145217 · COMPLETED

Trial details

NCT number
NCT06145217
Sponsor
Xspray Pharma AB
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug-drug Interaction Study
Start date
2023-08-22
Primary completion
2023-08-22
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.